Shares of Qiagen NV (QGEN) reached $41.99 on [insert date], surpassing the average analyst 12-month target price of $41.47. This movement prompts analysts to either downgrade their expectations or adjust target prices higher based on underlying business developments.
Currently, there are 12 different analyst targets for Qiagen, with estimates ranging from a low of $36.00 to a high of $49.00, averaging $41.47 with a standard deviation of $3.874. Recent ratings consist of 7 Strong Buy, 1 Buy, 8 Hold, and no Sell or Strong Sell ratings, indicating a generally positive outlook on the stock.
The average rating for Qiagen reports a score of 2.03 on a scale where 1 is Strong Buy and 5 is Strong Sell, highlighting strong analyst support for the stock.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
